International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic.
作者信息
Coles C E, Aristei C, Bliss J, Boersma L, Brunt A M, Chatterjee S, Hanna G, Jagsi R, Kaidar Person O, Kirby A, Mjaaland I, Meattini I, Luis A M, Marta G N, Offersen B, Poortmans P, Rivera S
机构信息
Oncology Department, University of Cambridge, UK.
University of Perugia, Italy; Perugia General Hospital Sant'Andrea delle Fratte, Italy.
出版信息
Clin Oncol (R Coll Radiol). 2020 May;32(5):279-281. doi: 10.1016/j.clon.2020.03.006.
Abstract
摘要
相似文献
1
International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic.
Clin Oncol (R Coll Radiol). 2020 May;32(5):279-281. doi: 10.1016/j.clon.2020.03.006.
2
Breast Cancer Management During the COVID-19 Pandemic: the Radiation Oncology Perspective.
Curr Breast Cancer Rep. 2022;14(1):8-16. doi: 10.1007/s12609-022-00441-7. Epub 2022 Feb 26.
3
Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada.
Adv Radiat Oncol. 2020 Jun 19;5(4):749-756. doi: 10.1016/j.adro.2020.06.002. eCollection 2020 Jul-Aug.
4
Looking Back: International Practice Patterns in Breast Radiation Oncology From a Case-Based Survey Across 54 Countries During the First Surge of the COVID-19 Pandemic.
JCO Glob Oncol. 2023 Jul;9:e2300010. doi: 10.1200/GO.23.00010.
5
Breast Radiation Therapy Under COVID-19 Pandemic Resource Constraints-Approaches to Defer or Shorten Treatment From a Comprehensive Cancer Center in the United States.
Adv Radiat Oncol. 2020 Apr 1;5(4):582-588. doi: 10.1016/j.adro.2020.03.013. eCollection 2020 Jul-Aug.
6
Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST).
Breast. 2020 Aug;52:110-115. doi: 10.1016/j.breast.2020.05.006. Epub 2020 May 29.
7
Cancer or COVID-19? A Review of Guidelines for Safe Cancer Care in the Wake of the Pandemic.
SN Compr Clin Med. 2020;2(12):2691-2701. doi: 10.1007/s42399-020-00632-2. Epub 2020 Nov 21.
8
Adaptation of international coronavirus disease 2019 and breast cancer guidelines to local context.
World J Clin Oncol. 2021 Jan 24;12(1):31-42. doi: 10.5306/wjco.v12.i1.31.
9
Management of early-stage breast cancer patients during the coronavirus disease 2019 (COVID-19) pandemic: The experience in China from a surgical standpoint.
J Cancer. 2021 Feb 22;12(8):2190-2198. doi: 10.7150/jca.50501. eCollection 2021.
10
Omission of adjuvant radiotherapy for older adults with early-stage breast cancer particularly in the COVID era: A literature review (on the behalf of Italian Association of Radiotherapy and Clinical Oncology).
J Geriatr Oncol. 2021 Sep;12(7):1130-1135. doi: 10.1016/j.jgo.2021.05.008. Epub 2021 May 19.
引用本文的文献
1
Implementation of ultra-hypofractionated radiotherapy for breast cancer in the Netherlands in 2020-2023, using registry data and questionnaires.
Radiat Oncol. 2025 Jun 12;20(1):99. doi: 10.1186/s13014-025-02669-w.
2
Tolerance of Adjuvant Ultrahypofractionated Whole-Breast Radiation Therapy Employing Moderately Hypofractionated Sequential Boost: A Single Institution Analysis.
Adv Radiat Oncol. 2025 Mar 5;10(5):101756. doi: 10.1016/j.adro.2025.101756. eCollection 2025 May.
3
Ultrahypofractionated Adjuvant Breast Radiation Therapy (± Boost) and Virtual Consultations: Patient Perspectives at 1 Year.
Adv Radiat Oncol. 2024 Nov 5;10(1):101668. doi: 10.1016/j.adro.2024.101668. eCollection 2025 Jan.
4
Impact of the Coronavirus disease pandemic on early breast cancer.
Front Oncol. 2024 Nov 27;14:1412027. doi: 10.3389/fonc.2024.1412027. eCollection 2024.
5
The impact of the COVID-19 pandemic on clinical staging, pathological staging and surgical management of breast cancer patients.
Rep Pract Oncol Radiother. 2024 Mar 18;29(1):122-130. doi: 10.5603/rpor.99357. eCollection 2024.
6
Implementation of ultra-hypofractionated radiotherapy schedules for breast cancer during the COVID-19 pandemic in the Netherlands.
Clin Transl Radiat Oncol. 2024 Jun 14;47:100807. doi: 10.1016/j.ctro.2024.100807. eCollection 2024 Jul.
7
Ultrahypofractionation in postoperative radiotherapy for breast cancer: A single-institution retrospective cohort series.
Cancer Med. 2024 Jul;13(13):e7367. doi: 10.1002/cam4.7367.
8
Breast cancer incidence, stage distribution, and treatment shifts during the 2020 COVID-19 pandemic: a nationwide population-level study.
Arch Public Health. 2024 May 7;82(1):66. doi: 10.1186/s13690-024-01296-3.
9
Toxicity of external beam accelerated partial-breast irradiation (APBI) in adjuvant therapy of early-stage breast cancer: prospective randomized study.
Radiat Oncol. 2024 Feb 3;19(1):17. doi: 10.1186/s13014-024-02412-x.
10
ESTRO-ACROP guideline for positioning, immobilisation and setup verification for local and loco-regional photon breast cancer irradiation.
Tech Innov Patient Support Radiat Oncol. 2023 Sep 12;28:100219. doi: 10.1016/j.tipsro.2023.100219. eCollection 2023 Dec.
本文引用的文献
1
Lessons Learned From Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology Patients.
Pract Radiat Oncol. 2019 Sep-Oct;9(5):305-321. doi: 10.1016/j.prro.2019.03.007. Epub 2019 Apr 15.
2
Hypofractionated Nodal Radiation Therapy for Breast Cancer Was Not Associated With Increased Patient-Reported Arm or Brachial Plexopathy Symptoms.
Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1166-1172. doi: 10.1016/j.ijrobp.2017.07.043. Epub 2017 Aug 3.
3
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
Lancet. 2017 Sep 9;390(10099):1048-1060. doi: 10.1016/S0140-6736(17)31145-5. Epub 2017 Aug 2.
4
Development of Postoperative Radiotherapy for Breast Cancer: UK Consensus Statements - a Model of Patient, Clinical and Commissioner Engagement?
Clin Oncol (R Coll Radiol). 2017 Oct;29(10):639-641. doi: 10.1016/j.clon.2017.06.011. Epub 2017 Jul 4.
5
Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial.
Radiother Oncol. 2016 Jul;120(1):114-8. doi: 10.1016/j.radonc.2016.02.027. Epub 2016 Apr 1.
6
First results of the preoperative accelerated partial breast irradiation (PAPBI) trial.
Radiother Oncol. 2015 Mar;114(3):322-7. doi: 10.1016/j.radonc.2015.02.002. Epub 2015 Feb 17.
7
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.
Lancet Oncol. 2015 Mar;16(3):266-73. doi: 10.1016/S1470-2045(14)71221-5. Epub 2015 Jan 28.
8
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial.
Eur J Cancer. 2015 Mar;51(4):451-463. doi: 10.1016/j.ejca.2014.12.013. Epub 2015 Jan 17.
9
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
Lancet Oncol. 2015 Jan;16(1):47-56. doi: 10.1016/S1470-2045(14)71156-8. Epub 2014 Dec 9.
10
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
Lancet Oncol. 2013 Oct;14(11):1086-1094. doi: 10.1016/S1470-2045(13)70386-3. Epub 2013 Sep 19.
Zotero 插件